Veeva Systems

NYSE: VEEV

Stock price

284.84 USD

(-0.58%) 5 years

Financial Performance

Share

5Y price score: 0

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 633.4%

DATE RANGE:

%

ㅤ

By default your notes are visible only to you.

148.0

52-week range

303.3

284.84

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

3.5 %

Dividend Yield TTM

-

Market cap $

$ 46,270

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

46.8

Price / Book TTM

6.2

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

1.8

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

(5.6) %

(0.6) %

633.4 %

Free cash flow per share growth

0.7 %

145.9 %

1,939.5 %

Earnings per share growth

39.5 %

130.5 %

1,331.6 %

Founded: 2,007

Employees: 7,291

Business Summary:Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.

Q&A

Get answers on financials, industry, fundamentals or other questions.

Contribute

By providing well-researched and detailed answer you increase your chance of becoming Top Contributor. TopFunds is free for all top contributors. Learn more

Fair Value Reference Estimate

Latest Earnings Call Takeaways

2027 Q2 (Aug 26, 2026)

1) Strong Financial Performance - Total revenue for Q2 2027 reached $928 million, exceeding guidance. - Non-GAAP operating income was $416 million. - Commercial subscriptions grew 13% year-over-year, with broad-based strength across CRM, content, data, and Crossix.

2) AI and Product Innovations - Veeva is accelerating in AI, particularly with the introduction of Veeva Falcon, which is generating high customer interest. - Falcon is seen as a transformative product, enabling faster implementation and efficiency in operations. - The company is also developing Aspen, a new CRM solution aimed at smaller, nimble companies, focusing on simplicity and predictability in pricing.

3) Market Dynamics and Customer Sentiment - There is a positive sentiment in biopharma R&D spending, leading to increased customer interest in Veeva's offerings. - Customers are looking for reliable AI solutions from established vendors rather than experimenting with new entrants. - Veeva is confident in winning back customers who previously chose Salesforce, citing execution and product reliability as key differentiators.

4) Challenges and Strategic Focus - Veeva faces competition from Salesforce, particularly with some large customers experiencing difficulties in their transitions. - The company is focused on maintaining strong relationships with existing customers and ensuring successful implementations to foster trust. - There are ongoing discussions about the potential for increased investments in R&D and sales to support new product launches.

5) Guidance and Future Outlook - Veeva has raised its guidance for FY 2027, reflecting confidence in continued growth across its product lines. - The company is optimistic about the long-term trajectory of its R&D business and the successful rollout of new AI-driven products. - There is a commitment to maintaining a balance between growth and profitability as new markets are explored.

Bottom line: Veeva's strong Q2 performance, driven by robust revenue growth and innovative AI product offerings, positions the company favorably for future expansion, particularly as it seeks to capitalize on the growing demand for reliable AI solutions in the biopharma sector.

Annual Reports, Presentations And IR Contacts

Go to the website

Veeva Systems — Financial Overview, Stock Price, Market Cap

Veeva Systems is a company. Founded in 2007. As of October 9, 2026, the company's market capitalization is $46270347008 with a current stock price of $284.84.